Key Insights

Highlights

Treatment Research

2 treatments under study, led by Cart Cells Targeting Epcam

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03563326Phase 1Unknown

Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)

Showing all 1 trials

Research Network

Common Treatments

  • Cart Cells Targeting Epcam1
  • Chemotherapy1

Active Sponsors

  • Jian-Kun Hu1

Top Investigators

Related Conditions

  • Metastases Neoplasm1
  • Neoplasm Stomach1

Activity Timeline